Comparative literature assessing the relative safety and efficacy of different BoNT products is limited.   The quantity and quality of data vary by preparation and indication.  Clinicians seeking data relevant to the care of patients with specific conditions may find only reports about small numbers of patients with varying symptoms.  While a literature search for “botulinum neurotoxins” will yield a large number of publications; only a fraction of these meet criteria for an academic evidence-based review.  Patients may have been treated with a different BoNT formulation than that with which the physician is familiar, or there may be little or no clinical data on the use of a specific BoNT product for the proposed intervention. An expert panel reviewed the BoNT clinical trial literature in order to provide evidence-based recommendations regarding the clinical use and efficacy of available BoNT preparations for four major therapeutic areas: movement disorders, spasticity, urology, and secretory disorders as well as mechanism of action. Expert opinion is also included to address practical issues where more evidence and further research is needed.

In order to receive a certificate for this activity:

  1. Read the CME information page.
  2. Review the special section of Toxicon
  3. Log-in or Register to Complete the CME Post-Test and evaluation.
  4. A link to your certificate will be e-mailed to you within 24 hours of satisfactory completion of these documents.

Evidence-Based Review and Consensus on the Science, Clinical Utility, and Safety of Botulinum Neurotoxin

Begin Quiz